These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
180 related articles for article (PubMed ID: 3296438)
1. [Immunoreactivity in tumor growth]. Fel' VIa Vopr Onkol; 1987; 33(4):99-106. PubMed ID: 3296438 [No Abstract] [Full Text] [Related]
2. Cancer immunosurveillance and immunoediting: the roles of immunity in suppressing tumor development and shaping tumor immunogenicity. Smyth MJ; Dunn GP; Schreiber RD Adv Immunol; 2006; 90():1-50. PubMed ID: 16730260 [TBL] [Abstract][Full Text] [Related]
3. Lymphocyte mediated cytotoxicity to tumor antigens. Hellström I; Hellström KE Johns Hopkins Med J Suppl; 1974; 3():37-50. PubMed ID: 4608238 [No Abstract] [Full Text] [Related]
4. [The "immunologic portrait" and tumorigenicity of neoplastic cells induced in mice by 3-methylcholanthrene]. Iaroslavtseva OA; Viksler VKh; Lavrovskiĭ VA Eksp Onkol; 1988; 10(6):26-9. PubMed ID: 3243190 [TBL] [Abstract][Full Text] [Related]
5. The flip side of immune surveillance: immune dependency. Prehn RT; Prehn LM Immunol Rev; 2008 Apr; 222():341-56. PubMed ID: 18364013 [TBL] [Abstract][Full Text] [Related]
6. The Yin-Yang of tumor-associated macrophages in neoplastic progression and immune surveillance. Allavena P; Sica A; Garlanda C; Mantovani A Immunol Rev; 2008 Apr; 222():155-61. PubMed ID: 18364000 [TBL] [Abstract][Full Text] [Related]
7. [A new hypothesis on the immune surveillance of tumors]. Jansa P Acta Univ Palacki Olomuc Fac Med; 1984; 107():139-42. PubMed ID: 6242634 [No Abstract] [Full Text] [Related]
8. On immunosurveillance in human cancer. Thomas L Yale J Biol Med; 1982; 55(3-4):329-33. PubMed ID: 6758376 [TBL] [Abstract][Full Text] [Related]
9. Tumor immunology. Shehadeh IH J Med Liban; 1972; 25(3):199-203. PubMed ID: 5086706 [No Abstract] [Full Text] [Related]
10. [Role of tissue microenvironment in immunity in the neoplastic process]. Janik P Pol Tyg Lek; 1983 May 30-Jun 6; 38(22-23):705-7. PubMed ID: 6316304 [No Abstract] [Full Text] [Related]
11. [Immunological properties of tumor cells that determine the degree of their malignancy]. Lavrovskiĭ VA; Viksler VKh Usp Sovrem Biol; 1981; 91(2):228-40. PubMed ID: 7018110 [No Abstract] [Full Text] [Related]
13. [Natural cytotoxic cells (NK) and their role in the immunological control of neoplasms]. Rupniewska ZM; Adamczyk MB Postepy Hig Med Dosw; 1981; 35(1):37-52. PubMed ID: 6174960 [No Abstract] [Full Text] [Related]
14. Tumor progression in vitro: the paradoxical natural antibody and complement-selected phenotype. Chow DA; Chan J Nat Immun Cell Growth Regul; 1987; 6(4):189-204. PubMed ID: 3683415 [TBL] [Abstract][Full Text] [Related]
15. Genes coding for tumor rejection antigens: perspectives for specific immunotherapy. Boon T; Coulie P; Marchand M; Weynants P; Wölfel T; Brichard V Important Adv Oncol; 1994; ():53-69. PubMed ID: 8206495 [No Abstract] [Full Text] [Related]
16. [Immunological processes and their morphological manifestations in the development of tumors]. Ageev AK Arkh Patol; 1974; 36(6):72-80. PubMed ID: 4137423 [No Abstract] [Full Text] [Related]
17. [Rearrangements in cell populations in malignant growth]. Shuklinov VA Eksp Onkol; 1984; 6(6):25-30. PubMed ID: 6396066 [TBL] [Abstract][Full Text] [Related]
19. [1 of the pathways for normalization of populations of malignant cells]. Shuklinov VA Tsitologiia; 1985 Mar; 27(3):268-75. PubMed ID: 3887700 [TBL] [Abstract][Full Text] [Related]
20. [Effects of treatment with neuraminidase on the immunogenicity of ATPC tumor cells]. Iorio AM; Rivosecchi P; Santoni A; Fabiani L Boll Soc Ital Biol Sper; 1973 Mar; 49(9):462-6. PubMed ID: 4787510 [No Abstract] [Full Text] [Related] [Next] [New Search]